News Archive

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vel sem cursus turpis vehicula finibus. Vivamus eget lectus suscipit, consequat ipsum sit amet, ultrices erat. Fusce vitae gravida nunc, non viverra mi. Duis et pharetra justo. Nulla quis mattis tellus, quis porttitor tortor. Praesent at arcu nec eros maximus vehicula. Donec at nibh magna. Maecenas eget odio sapien. Nunc et ornare augue, ac cursus augue. In malesuada magna urna, at rhoncus magna fermentum non. Donec porttitor velit nec odio commodo blandit. Etiam vitae tortor mauris. In et tincidunt purus, at facilisis purus. Nam condimentum lectus id arcu dictum tristique.

Pellentesque est neque, dignissim quis rhoncus in, eleifend at nunc. Fusce ultrices pretium consectetur. Duis euismod venenatis orci. Morbi ultrices congue enim, id iaculis mauris. Ut facilisis orci eget ipsum fringilla pretium eu quis purus. Maecenas laoreet nisi erat, quis venenatis purus vehicula et. Mauris ut purus vel augue consectetur sollicitudin vel quis magna. Nam eget elit nisl.

Updated again

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Updated new

We’re thrilled to announce that Novartis, a proudly Swiss company, is an official partner of the Eurovision Song Contest 2025, hosted in our headquarters city of Basel, Switzerland.

Novartis announced it has partnered with Versant Ventures (Versant) to form Borealis Biosciences (Borealis), an independent, discovery-stage biotechnology company based in Vancouver, Canada, focused on developing next-generation xRNA-based medicines for kidney diseases. xRNA, a core technology platform for Novartis, can target the body’s natural mRNA to modulate the production of proteins that cause disease.

Novartis poised to expand impact on human health as it begins next era.

Over 1 billion people volunteer worldwide, sharing their skills and experience, providing support within their communities, and offering emergency assistance to those in need. On International Volunteer Day (December 5), we join forces with the UN to recognize the tireless work of all volunteers and the contributions that they make.

Through the Avoidable Blindness Program, Novartis is working with partners to strengthen eye health in sub-Saharan Africa.

Developing treatments for blood cancers and serious blood disorders is important, but it is only part of the equation. We also need to help ensure those who may need our therapies can get them.

Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.

Despite advancements in care, prostate cancer is one of the most frequently diagnosed cancers around the world. This Movember, we’re focused on raising awareness of prostate cancer.